| Patient |
Risk group |
CD4/CD3 count (cells/µl) |
Viral load (copies/ml) |
NRTI |
NNRTI |
DRUGS AFFECTED |
| 1 |
Blood transfusion |
131/830 |
401,000 |
V75I |
A98V |
Potential low-level resistance: stavudine, didanosine. |
| 2 |
Heterosexual |
110/603 |
245,000 |
K219Q |
|
Potential low-level resistance: stavudine, Low-level resistance: zidovudine. |
| 3 |
Heterosexual |
181/1005 |
29,600 |
|
V179D |
Potential low-level resistance: delavirdine, efavirenz, etravirine, nevirapine. |
| 4 |
Heterosexual |
176/1518 |
81,700 |
|
V179D |
Potential low-level resistance: delavirdine, efavirenz, etravirine, nevirapine |
| 5 |
Heterosexual |
59/853 |
1750,000 |
|
V179D |
Potential low-level resistance:delavirdine, efavirenz, etravirine, nevirapine |
| 6 |
Heterosexual |
50/265 |
1150,000 |
|
G190A |
Intermediate resistance:efavirenz, Low-level resistance:etravirine, High-level resistance:nevirapine |
| 7 |
Heterosexual |
510/3336 |
11,100 |
|
K103N |
High-level resistance:delavirdine, efavirenz, nevirapine, Potential low-level resistance:etravirine |
| 8 |
Heterosexual |
510/2822 |
92,200 |
|
G190V |
High-level resistance: efaviranz, nevirapine |
|
